Page last updated: 2024-08-25

alantolactone and B16 Melanoma

alantolactone has been researched along with B16 Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chen, J; Chen, Y; Huang, Q; Huang, Y; Li, Y; Pu, Y; Wei, M; Zhang, L; Zou, D	1

Other Studies

1 other study(ies) available for alantolactone and B16 Melanoma

Article	Year
Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling. Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:1 Topics: Animals; Apoptosis; bcl-2-Associated X Protein; beta Catenin; Cadherins; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Glycogen Synthase Kinase 3 beta; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Vimentin; Wnt Signaling Pathway	2023

Article

Year

Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/β-Catenin Signaling.

Anti-cancer agents in medicinal chemistry, 2023, Volume: 23, Issue:1

Topics: Animals; Apoptosis; bcl-2-Associated X Protein; beta Catenin; Cadherins; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Glycogen Synthase Kinase 3 beta; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Nude; Proliferating Cell Nuclear Antigen; Vimentin; Wnt Signaling Pathway

2023